5 Best Biotech Stocks Under $20 in Cathie Wood’s Portfolio

3. Compugen Ltd. (NASDAQ:CGEN)

Number of Hedge Fund Holders: 13

Share price as of November 24: $4.61

Another cheap biotech stock in Cathie Wood’s portfolio is Compugen Ltd. (NASDAQ:CGEN), a clinical-stage drug discovery company. The Israeli company is co-developing immuno-oncology pipelines with Bristol-Myers Squibb Company, Bayer AG, and AstraZeneca PLC.

Compugen Ltd. (NASDAQ:CGEN) accounted for 0.14% of the ARK Investment Management fund as of the end of the September quarter, with over 9.8 million shares worth $58.7 million.

Compugen Ltd. (NASDAQ:CGEN) reported an EPS of -0.07 in the third quarter, beating estimates by $0.05. The company’s revenue in the quarter was $6 million. 

There were 13 hedge funds that held a position in Compugen Ltd. (NASDAQ:CGEN) worth $79.6 million at the end of the third quarter, up from 11 in the previous quarter worth $126 million.